Researcher receives nearly $2 million to fight bird flu

Highly pathogenic avian influenza causes significant economic losses for farmers.

By Rochita Ghosh

Brown rooster

March 2, 2026

A researcher at the University of Missouri School of Medicine and College of Veterinary Medicine is working to develop a novel vaccine and strategy to protect animals and humans from avian influenza, commonly known as bird flu.

Professor Wenjun Ma has received a $1.9 million grant from the Animal and Plant Health Inspection Service under the U.S. Department of Agriculture for the work.

Highly pathogenic avian influenza (HPA1) is a widespread and highly contagious virus in birds that can spread to other animals and livestock. While human transmission is rare, the United States has seen 71 confirmed cases with 2 deaths since 2024.

“The HPAI H5N1 infection has caused significant economic losses for our farmers, like the egg shortages, and several issues with food safety and international trade,” Ma said. “Right now, outbreaks cannot be effectively controlled, despite best efforts to depopulate domestic birds on impacted and neighboring farms. This grant will help us develop a new vaccine that can differentiate infected animals from vaccinated ones, which will help curb current outbreaks in domestic poultry.”

Ma and his team will develop safe and effective vaccines that provide protection from not only the avian flu but also Newcastle disease, another fatal, viral disease in poultry. The researchers will test the vaccines’ safety and effectiveness in chickens and turkeys.

Ma will also collaborate with Curators’ Distinguished Professor Wesley Warren in the College of Agriculture, Food and Natural Resources, and John Driver, an associate professor in CAFNR, to understand how cells from a chicken’s lung communicate with each other and how the pulmonary network rewires itself after an HPAI infection.

“Developing this vaccine will benefit US farmers, poultry producers, stakeholders and anyone who may consume chicken or eggs,” Ma said. “It will also help protect international trade and ensure that HPAI does not spread to any human, sparing them from a disease for which we have no treatment.”

Read more from the School of Medicine

Subscribe to

Show Me Mizzou

Stay up-to-date with the latest news by subscribing to the Show Me Mizzou newsletter.

Subscribe